Director, Board of Directors
Mr. Paul Edick became a Director for Sucampo in July 2016. He currently serves as Founding Partner at 3G Advisors, a consultancy to the pharmaceutical, healthcare and healthcare investor communities. From 2010 to 2014, Mr. Edick was Chief Executive Officer and board member of Durata Therapeutis, a public biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases. Prior to Durata, he was Chief Executive Officer of Ganic Pharmaceuticals, Inc., a Warburg Pincus investment search vehicle, and prior to that he was Chief Executive Officer at MedPoint Healthcare, Inc. Mr. Edick has also held a number of senior positions at GD Searle & Company, and at Pharmacia Corporation following its acquisition of the company, culminating in his appointment as Pharmacia’s Group Vice President and President for Asia and Latin America.
He is a member of the Board of Directors of PDL BioPharma, Inc., NewLink Genetics, Inc. and Neos Therapeutics, Inc. Mr. Edick is also Chairman of the Board of Iterum Therapeutics, a private company.
Mr. Edick earned a bachelor’s degree in Psychology from Hamilton College in Clinton, NY.